Welcome to our dedicated page for Nortech Sys SEC filings (Ticker: NSYS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking a multi-industry manufacturer like Nortech Systems Inc. can be daunting—every 10-K details medical-device regulations, while each 8-K flags aerospace contract wins or supply-chain delays. Hunting for segment margins or deciphering customer-concentration tables across hundreds of pages takes time investors rarely have.
That’s why Stock Titan pairs real-time EDGAR feeds with AI-powered summaries. The moment a Nortech Systems quarterly earnings report 10-Q filing arrives, our engine highlights revenue by EMS factory, backlog shifts and quality-assurance costs—Nortech Systems SEC filings explained simply. Need immediate visibility into Nortech Systems insider trading Form 4 transactions? We surface every director buy or sell, with Nortech Systems Form 4 insider transactions real-time alerts so you can gauge sentiment before volume spikes. Our coverage spans the full slate of disclosures:
- Annual report insights with Nortech Systems annual report 10-K simplified for supply-chain risk, customer mix, and R&D spend.
- Flash notes on Nortech Systems 8-K material events explained—from new defense contracts to leadership changes.
- Clean breakdowns of Nortech Systems proxy statement executive compensation so you understand incentive structures.
- Concise tables for Nortech Systems executive stock transactions Form 4 and related footnotes.
Whether you’re comparing quarter-over-quarter plant utilization or performing a Nortech Systems earnings report filing analysis, our expert commentary and AI give you the context you need. Stop scrolling through dense PDFs and start understanding Nortech Systems SEC documents with AI—all filings, all in one place, updated the instant they post.
Nortech Systems (NSYS) filed its Q3 2025 10‑Q, showing net sales of $30.5 million versus $31.4 million a year ago. Gross margin improved to 16.5% from 12.2%, lifting operating results to $0.9 million of operating income from a prior‑year loss. The quarter ended with a net loss of $0.1 million, compared with a $0.7 million loss last year.
Year‑to‑date, net sales were $88.1 million versus $99.5 million, with operating income of $0.1 million and a net loss of $1.1 million. Aerospace and Defense softness and plant transfers weighed on revenue, while Medical Imaging grew. The 90‑day backlog rose to $31.3 million, up 17.8% from the start of the quarter, and total backlog was $77.3 million. Cash was $1.3 million, and the line of credit balance was $12.0 million, classified as current. Management noted that the revolver maturing on August 31, 2026 initially raised substantial doubt under accounting guidance, but term sheets and a refinancing plan alleviated that doubt. Operating cash flow used was $2.9 million for the first nine months.
Nortech Systems Incorporated reported a planned board transition. Director Debarati Sen notified the company she will not stand for re‑election for the 2026–2027 term and will continue to serve through the annual meeting in May 2026. The company stated her decision was not the result of any disagreement regarding operations, policies, or practices.
This update reflects routine board refreshment disclosed under Item 5.02 of Form 8‑K and does not change the company’s day‑to‑day operations.
FAQ
What is the current stock price of Nortech Sys (NSYS)?
What is the market cap of Nortech Sys (NSYS)?
